Epigenetic regulation of the embryonic oncogene ERas in gastric cancer cells

  • Authors:
    • Masakazu Yashiro
    • Koichi Yasuda
    • Takafumi Nishii
    • Ryoji Kaizaki
    • Tetsuji Sawada
    • Masaichi Ohira
    • Kosei Hirakawa
  • View Affiliations

  • Published online on: November 1, 2009     https://doi.org/10.3892/ijo_00000414
  • Pages: 997-1003
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

ERas is a recently identified oncogene that supports the tumorigenic growth of embryonic stem cells, it is constitutively active in the absence of mutation. ERas oncogene is expressed only in viviparity phase cells, but not in somatic cells because of epigenetic transcriptional silencing in the somatic phase. The aim of this study was to clarify the ERas expression and its epigenetic regulation in gastric cancer of somatic phase. Fifteen gastric cancer cell lines were used. ERas mRNA expression and its epigenetic regulation were examined by reverse transcription-polymerase chain reaction and bisulfite sequencing analysis. To identify a subset of cancer stem cells, termed ‘side population’ (SP) cells, flow cytometry analysis was performed. ERas is expressed in 8 of the 15 gastric cancer cell lines, but is silenced in the remaining 7 cancer cell lines and normal cell lines. Six of 7 cancer cell lines without ERas expression had promoter methylation, which correlated with silencing of ERas expression. ERas expression is re-activated following treatment with the DNA methyltransferase inhibitor 5-aza-CdR. The percentage of SP fraction of ERas-positive gastric cancer cells was significantly (p=0.024) higher (3.4±1.8%), in comparison to that of ERas-negative cells (1.6±0.4%). These findings suggested that the activating ERas oncogene might be associated with tumorigenic growth of somatic cells, and might be a putative molecule responsible for cancer stem cell-like characteristics in gastric cancer. Loss of methylation in the promoter of ERas might be one of mechanisms responsible for the re-expression of an embryonic oncogene in gastric cancer.

Related Articles

Journal Cover

November 2009
Volume 35 Issue 5

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yashiro M, Yasuda K, Nishii T, Kaizaki R, Sawada T, Ohira M and Hirakawa K: Epigenetic regulation of the embryonic oncogene ERas in gastric cancer cells. Int J Oncol 35: 997-1003, 2009
APA
Yashiro, M., Yasuda, K., Nishii, T., Kaizaki, R., Sawada, T., Ohira, M., & Hirakawa, K. (2009). Epigenetic regulation of the embryonic oncogene ERas in gastric cancer cells. International Journal of Oncology, 35, 997-1003. https://doi.org/10.3892/ijo_00000414
MLA
Yashiro, M., Yasuda, K., Nishii, T., Kaizaki, R., Sawada, T., Ohira, M., Hirakawa, K."Epigenetic regulation of the embryonic oncogene ERas in gastric cancer cells". International Journal of Oncology 35.5 (2009): 997-1003.
Chicago
Yashiro, M., Yasuda, K., Nishii, T., Kaizaki, R., Sawada, T., Ohira, M., Hirakawa, K."Epigenetic regulation of the embryonic oncogene ERas in gastric cancer cells". International Journal of Oncology 35, no. 5 (2009): 997-1003. https://doi.org/10.3892/ijo_00000414